1 LIQUID BIOPSY: MARKET AT A GLANCE
1.1 INTRODUCTION
1.2 ISSUES ADDRESSED BY LIQUID BIOPSY & BIOMARKERS DETECTED
1.3 MILESTONES IN LIQUID BIOPSY

2 LIQUID BIOPSY: CIRCULATING BIOMARKERS
2.1 LIQUID BIOPSY MARKET FOR CIRCULATING TUMOR DNA (CTDNA)
2.2 CTDNA APPROACHES: APPLICATIONS AND LIMITATIONS
2.3 METHODS FOR CTC ISOLATION

3 LIQUID BIOPSY: MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 DRIVERS
3.1.2.1 HIGH BURDEN OF CANCER
3.1.2.2 INCREASING PREFERENCE FOR NONINVASIVE PROCEDURES
3.1.2.3 INITIATIVES UNDERTAKEN BY GOVERNMENTS
AND GLOBAL HEALTH ORGANIZATIONS
3.1.2.4 TECHNOLOGICAL ADVANCEMENTS
3.1.2.5 RISING EMPHASIS ON PERSONALIZED MEDICINE
3.1.2.6 AVAILABILITY OF FUNDING FOR LIQUID BIOPSY R&D
3.1.2 RESTRAINTS
3.1.2.1 LOW SENSITIVITY AND SPECIFICITY
3.1.3 OPPORTUNITIES
3.1.3.1 GROWING INTEREST IN LIQUID BIOPSY
3.1.4 CHALLENGES
3.1.4.1 UNCLEAR REGULATORY AND REIMBURSEMENT SCENARIO

4 MAJOR INVESTMENTS & INITIATIVES
4.1 GOVERNMENT FUNDING & INITIATIVES
4.2 INDUSTRY INVESTMENTS AND INITIATIVES

5 BREAST CANCER LIQUID BIOPSY MARKET
5.1 BREAST CANCER LIQUID BIOPSY MARKET: GLOBAL SCENARIO
5.2 POTENTIAL OF LIQUID BIOPSY AND CTC IN BREAST CANCER DIAGNOSIS

?

6 LIQUID BIOPSY MARKET: COMPETITIVE LANDSCAPE
6.1 INTRODUCTION
6.2 KEY STRATEGIES
6.2.1 ACQUISITIONS AND MERGERS
6.2.2 PRODUCT LAUNCHES
6.2.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
6.3 LIQUID BIOPSY MARKET: COMPETITIVE TECHNOLOGY PORTFOLIO

7 APPENDIX
7.1 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
7.2 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
7.3 AVAILABLE CUSTOMIZATIONS
7.4 RELATED REPORTS
7.5 AUTHOR DETAILS